Skip to main content

Hypothetical Role of Endothelin in the Control of the Cardiovascular System

  • Chapter
Endothelin

Part of the book series: Clinical Physiology Series ((CLINPHY))

Abstract

The discovery that vascular endothelial cells can synthesize autocrine and paracrine substances that can alter the tone of the underlying smooth muscle and inhibit the aggregation of platelets revealed novel mechanisms that may contribute to cardiovascular homeostasis. This began with a series of studies that led to the discovery of prostacyclin41 and was followed by the demonstration that endothelial cells also form a nonprostanoid substance that was termed “endothelium-derived relaxing factor” (EDRF).21 Subsequent studies have shown that the major EDRF is nitric oxide or a labile nitroso compound20,27 formed from L-arginine in the endothelial ce11.42

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Badr, K., J. Murray, M. Breyer, K. Takahashi, T. Inagami, and R. Harris. Mesangial cell, glomerular, and renal vascular responses to endothelin in the rat kidney. J. Clin. Invest. 83: 336–342, 1989.

    Article  PubMed  CAS  Google Scholar 

  2. Boarder, M. R., and D. B. Marriott. Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromaffin cells. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S223–S224, 1989.

    Article  PubMed  CAS  Google Scholar 

  3. Boulanger, C., and T. F. L Uscher. Release of endothelin from the porcine aorta—inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85: 587–590, 1990.

    Article  PubMed  CAS  Google Scholar 

  4. Bonhomme, M. C., M. Cantin, and R. Garcia. Relaxing effect of atrial natriuretic factor on endothelin-precontracted strips. Proc. Soc. Exp. Biol. Med. 191: 309–315, 1989.

    PubMed  CAS  Google Scholar 

  5. Brown, A. M. Receptors under pressure: an update on baroreceptors. Circ. Res. 46: 1–10, 1980.

    Article  PubMed  CAS  Google Scholar 

  6. Chapleau, M. W., G. Hajduczok and F. M. Abboud. Mechanisms of resetting of arterial baroreceptors: an overview. Am. J. Med. Sci. 295 (4): 327–334, 1988.

    Article  PubMed  CAS  Google Scholar 

  7. Chapleau, M. W., G. Hajduczok, and F. M. Abboud. Endothelin suppresses baroreceptor activity: a new mechanism contributing to hypertension?, abstracted. Hypertension 14 (3): 336, 1989.

    Google Scholar 

  8. Clozel, M., and W. FiscHli Human cultured endothelial cells do secrete endothelin-1 J. Cardiovasc. Pharmacol. 13 (Suppl. 5): 5229–5231, 1989.

    Google Scholar 

  9. Cocks, T. M., S. J. King, R. A. Woods, and J. A. Angus. Hemoglobin increases the amount of endothelin present in conditioned media of cultured endothelial cells. Proc. Aust. Physiol. Pharmacol. Soc. 20: 115, 1989.

    Google Scholar 

  10. Cozza, E. N., C. E. Gomezsanchez, M. F. Foecking, and S. Chiou. Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J. Clin. Invest. 84: 1032–1035, 1989.

    Article  PubMed  CAS  Google Scholar 

  11. Davenport, A. P., D. J. Nunez, J. A. Hall, A. J. Kaumann, and M. J. Brown. Autoradiographical localization of binding sites for porcine [125]endothelin-1 in humans, pigs, and rats: functional relevance in humans. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S166–S170, 1989.

    Article  PubMed  CAS  Google Scholar 

  12. Demey, J. G., M. Claeys, and P. M. Vanhoutte. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. J. Pharmacol. Exp. Ther. 222: 166–173, 1983.

    Google Scholar 

  13. Demey, J. G., and P. M. Vanhoutte. Heterogenous behavior of the canine arterial and venous wall. Circ. Res. 51: 439–447, 1982.

    Article  CAS  Google Scholar 

  14. DE Nucci, G. R., R. Thomas, P. D’OrlËAns-Juste, E. Antunes, T. D. Walder, and J. R. Vane. Pressor effects of circulatory endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. Usa 85: 9797–9800, 1988.

    Article  PubMed  Google Scholar 

  15. Dubin, D., R. E. Pratt, J. P. Cooke, and V. J. DzAU. Endothelin, a potent vasoconstrictor, is a vascular smooth-muscle mitogen, abstracted. Clin. Res. 37: 517, 1989.

    Google Scholar 

  16. Dzau, V. J., and G. H. Gibbons. Cell biology of vascular hypertension in systemic hypertension. Am. J. Cardiol. 62: 30G - 35G, 1988.

    Article  PubMed  CAS  Google Scholar 

  17. Emori, T., Y. Hirata, K. Ohta, M. Shichirn, and F. Marumo. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem. Biophys. Res. Commun. 160: 93–100, 1989.

    Article  PubMed  CAS  Google Scholar 

  18. Ferrario, R. G., R. FouLkes, P. Salvati, C. Patrons. Hemodynamic and tubular effects of endothelin and thromboxane in the isolated perfused rat kidney. Eur. J. Pharmacol. 171: 127–134, 1989.

    Article  PubMed  CAS  Google Scholar 

  19. Fukuda, Y., Y. Hirata, H. Yshimi, T. Kojima, Y. Kobayashi, M. Yanagisawa, and T. Masaki. Endothelin is a potent secretagogue for atrial natriuretic peptide cultured in rat atrial myocytes. Biochem. Biophys. Res. Commun. 155 (1): 167–172, 1988.

    Article  PubMed  CAS  Google Scholar 

  20. Furchgott, R. F., M. T. Khan, and D. Jothianandan. Comparison of endothelium dependent relaxation and nitric oxide induced relaxation in rabbit aorta, abstracted. Federation Proc. 46: 385, 1987.

    Google Scholar 

  21. Furchgott, R. F., and J. V. Zawadzki. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376, 1980.

    Article  PubMed  CAS  Google Scholar 

  22. Goetz, K. L., B. C. Wang, J. B. Madwed, J. L. Zhu, R. J. Leadley, JR. Cardiovascular, renal and endocrine responses to intravenous endothelin in conscious dogs. Am. J. Physiol. 255 (Regulatory Integrative Comp. Physiol. 24 ): R1064 - R1068, 1988.

    Google Scholar 

  23. Harder, D. R. Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelim. Circ. Res. 60: 102–107, 1987.

    Article  PubMed  CAS  Google Scholar 

  24. Heesch, C. M., F. M. Abboud, and M. D. Thames. Acute resetting of carotid sinus baro-receptors. II. Possible involvement of electrogenic Na pump. Am. J. Physiol. 247: (Heart Circ. Physiol. 16 ): H833 - H834, 1984.

    Google Scholar 

  25. Hickey, K. A., G. Rubanyi, R. J. Paul, and R. F. Highsmith. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am. J. Physiol. 248 (Cell Physiol. 17): C550–0556, 1985.

    CAS  Google Scholar 

  26. Hu, R. J., U. G. Berninger, and R. E. Lang. Endothelin stimulates atrial natriuretic peptide (Anp) release from rat atria. Eur. J. Pharmacol. 158: 177–178, 1988.

    Article  PubMed  CAS  Google Scholar 

  27. Ignarro, L. J., R. Byrns, and K. S. Wood. Pharmacological and biochemical properties of Edrf: evidence that Edrf is closely related to nitric oxide radical, abstracted. Circ. Res. 74 (Suppl. II): II - 287, 1986.

    Google Scholar 

  28. Katusic, Z. S., J. T. Shepherd, and P. M. Vanhoutte. Endothelium-dependent contractions to stretch in canine basilar arteries, abstracted. Federation Proc. 45: 289, 1986.

    Google Scholar 

  29. Kawaguchi, H., K. Ito, and H. Yasuda. Endothelin stimulates angiotensin converting enzyme activity. Presented at The International Society of Hypertension, 13th Scientific Meeting, Montreal, December 1990.

    Google Scholar 

  30. Khayutin, V. M., A. M. Melkumyants, A. N. RoGoza, E. S. Veselova, S. A. Balashov, and V. P. Nikolsky. Flow-induced control of arterial lumen, abstracted. Acta Physiol. Hung. 68: 334, 1989.

    Google Scholar 

  31. King, A. J., B. M. Brenner, and S. Anderson Endothelin: a potent renal and systemic vasoconstrictor peptide. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25 ): F1051 - F1058, 1989.

    Google Scholar 

  32. King, A. J., J. M. Pfeffer, M. A. Pfeffer, and B. M. Brenner. Systemic hemodynamic effects of endothelin in the rat. Am. J. Physiol. 258: (Heart Circ. Physiol. 27 ): H787 - H792, 1990.

    Google Scholar 

  33. Knuepfer, M.M., S. P. Han, A. J. Trapani, K. F. Fox, and T. C. Westfall. Regional hemodynamic and baroreflex effects of endothelin in rats. Am. J. Physiol. 257 (Heart Circ. Physiol. 26 ): H918 - H926, 1989.

    Google Scholar 

  34. Kohzuki, M., C. I. Johnston, S. Y. Chai, D. J. Casley, F. Rogerson, and F. A. O. Mendelsohn. Endothelin receptors in rat adrenal gland visualized by quantitative autoradiography. Clin. Exp. Pharmacol. Physiol. 14 (4): 239–242, 1989.

    Article  Google Scholar 

  35. Koseki, C., M. Imai, Y. Hirata, M. Yanagisawa, and T. Masaki. Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide ? Am. J. Physiol. (Regulatory Integrative Comp. Physiol. 25 ): R858 - R866, 1989.

    Google Scholar 

  36. Langille, B. L., and F. O’Donnell. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231: 405–407, 1986.

    Article  PubMed  CAS  Google Scholar 

  37. Lopezfarre, A., I. Montanes, I. Millas, and J. Lopeznovoa. Effect of endothelin on renal function in rats. Eur. J. Pharmacol. 163: 187–189, 1989.

    Article  CAS  Google Scholar 

  38. Matsumura, Y., K. Nakase, R. Ikegawa, K. Hayashi, T. Ohyama, and S. Morimoto. The endothelin-derived vasoconstrictor peptide endothelin inhibits renin release in vitro. Life Sci. 44 (2): 149–157, 1989.

    Article  PubMed  CAS  Google Scholar 

  39. Mcdowell, T. S., T. S. Axtelle, M. W. Chapleau, and F. M. Abboud. Prostaglandins in carotid sinus enhance baroreflex in rabbits. Am. J. Physiol. 257 (Regulatory Integrative Comp. Physiol. 26 ): R445 - R450, 1989.

    Google Scholar 

  40. Miller, W. L., M. M. Redfield, and J. C. Burnett, JR. Integrated cardiac, renal, and endocrine actions of endothelin. J. Clin. Invest. 83: 317–320, 1989.

    Article  PubMed  CAS  Google Scholar 

  41. Moncada, S., R. Gryglewski, S. Bunting, and J. R. Vane. An enzyme isolated from arteries transforms prostaglandin endoperoxidase to an unstable substance that inhibits platelet aggregation. Nature 263: 663–665, 1976.

    Article  PubMed  CAS  Google Scholar 

  42. Morishita, R., J. Higaki, and T. Ogihara. Endothelin stimulates aldosterone biosynthesis by dispersed rabbit adreno-capsular cells. Biochem. Biophys. Res. Commun. 160 (2): 628–632, 1989.

    Article  PubMed  CAS  Google Scholar 

  43. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526, 1987.

    Article  PubMed  CAS  Google Scholar 

  44. Rakugi, H., M. Nakamaru, H. Saito, J. Higaki, and T. Ogigara. Endothelin inhibits renin release from isolated rat glomeruli. Biochem. Biophys. Res. Commun. 155(3): 12441247, 1988.

    Google Scholar 

  45. Rubanyi, G. M. Endothelium-dependent pressure-induced contraction of isolated canine carotid arteries. Am. J. Physiol. 255 (Heart Circ. Physiol. 24 ): H783 - H788, 1988.

    Google Scholar 

  46. Rubanyi, G. M. Endothelium-derived vasoconstrictor factors. In: Endothelial Cell, edited by U. S. Ryan. Cleveland, OH: Crc, 1985, vol. Iii, p. 61–74.

    Google Scholar 

  47. Rubanyi, G. M. Maintenance of “basal” vascular tone may represent a physiological role for endothelin. J. Vase. Med. Biol. 6: 315–316, 1989.

    Google Scholar 

  48. Rubanyi, G. M., C. J. Romero and P. M. Vanhoutte. Flow-induced release of endothelium-derived relaxing factor. Am. J. Physiol. 250 (Heart Circ. Physiol. 19 ): H1145 - H1149, 1986.

    Google Scholar 

  49. Rubanyi, G. M., and P. M. Vanhoutte. Hypoxia releases a vasoconstrictor substance from canine vascular endothelium. J. Physiol. 364: 45–56, 1985.

    PubMed  CAS  Google Scholar 

  50. Schini, V. B., H. Hendrickson, D. M. Heublein, J. C. Burnett, JR., and P. M. Vanhoutte. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur. J. Pharmacol. 165: 333–334, 1989.

    Article  PubMed  CAS  Google Scholar 

  51. Stasch, J. P., C. Hirth-Dietrich, S. Kazda, D. Neuser. Endothelin stimulates release of natriuretic peptides in vitro and in vivo. Life Sci. 45 (10): 869–875, 1989.

    Article  PubMed  CAS  Google Scholar 

  52. Tabuchi, Y., M. Nakamuru, H. Rakugi, M. Nagano, H. Mikami, and T. Ogihara. Endothelin interacts with the neuroeffector junction in rat mesenteric artery, abstracted. Hypertension 14 (3): 336, 1989.

    Google Scholar 

  53. Takagi, M., H. Matsuoka, K. Atarashi, and S. Yagi. Endothelin: a new inhibitor of renin release. Biochem. Biophys. Res. Commun. 157 (3): 1164–1168, 1988.

    Article  PubMed  CAS  Google Scholar 

  54. Takashi, H., M. Nishimura, M. Matsusawa, I. Ikegaki, M. Sakamoto, and M. Yoshimura. Centrally-induced cardiovascular effects. of endothelin in conscious rats. Presented at The International Society of Hypertension, 13th Scientific Meeting, Montreal, December 1990.

    Google Scholar 

  55. Tesfamariam, B., and R. A. Cohen. Inhibition of adrenergic vasoconstriction by endothelial cell shear stress. Circ. Res. 63: 720–725, 1988.

    Article  PubMed  CAS  Google Scholar 

  56. Thiemermann, C., P. S. Lidbury, G. R. Thomas, and J. R. Vane. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S138 - S141, 1989.

    Article  PubMed  CAS  Google Scholar 

  57. Vanhoutte, P. M., W. Auch-Schwelk, and C. Boulanger. Does endothelin-1 mediate endothelium-dependent contractions during anoxia? J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S124 - S128, 1989.

    Article  PubMed  CAS  Google Scholar 

  58. Winquist, R. J., A. L. Scott, and G. P. Vlasuk. Enhanced release of atrial natriuretic factor by endothelin in atria from hypertensive rats. Hypertension 14 (1): 111–114, 1989.

    Article  PubMed  CAS  Google Scholar 

  59. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kabayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988.

    Article  PubMed  CAS  Google Scholar 

  60. Yashizawa T, O. Shinmi, A. Giaid, M. Yanagisawa, J. Gibson, S. Kimura, Y. Ochiyama, J. M. Polak, T. Masaki, and I. Kanazawa. Endothelin is a novel peptide in the posterior pituitary system. Science 247: 462–464, 1990.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 American Physiological Society

About this chapter

Cite this chapter

Rubanyi, G.M., Shepherd, J.T. (1992). Hypothetical Role of Endothelin in the Control of the Cardiovascular System. In: Rubanyi, G.M. (eds) Endothelin. Clinical Physiology Series. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7514-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7514-9_16

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-7514-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics